Hologic receives FDA approval for hydroxyprogesterone caproate injection

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today the U.S. Food and Drug Administration (FDA) has approved Hologic's pharmaceutical named Makena™ (hydroxyprogesterone caproate injection), formerly known as Gestiva™. Per the terms of an asset purchase agreement (the Agreement) between Hologic and KV Pharmaceutical Company (KV), Hologic will transfer the Company's Makena assets (the Transfer) to KV upon the satisfaction of certain conditions, including receipt of a $12.5 million cash payment from KV. Transfer is expected to be completed by February 11, 2011.

Under the Agreement, Hologic has already received $79.5 million in cash payments from KV, plus reimbursement of Hologic's expenses relating to Makena. In addition to the $12.5 million cash payment expected to be received by February 11, 2011, KV is required to make additional payments to Hologic totaling $107.5 million over a period not to exceed 30 months, which will result in a total purchase price of $199.5 million.

Source:

Hologic, Inc

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Hologic, Inc.. (2019, June 24). Hologic receives FDA approval for hydroxyprogesterone caproate injection. News-Medical. Retrieved on February 08, 2023 from https://www.news-medical.net/news/20110204/Hologic-receives-FDA-approval-for-hydroxyprogesterone-caproate-injection.aspx.

  • MLA

    Hologic, Inc.. "Hologic receives FDA approval for hydroxyprogesterone caproate injection". News-Medical. 08 February 2023. <https://www.news-medical.net/news/20110204/Hologic-receives-FDA-approval-for-hydroxyprogesterone-caproate-injection.aspx>.

  • Chicago

    Hologic, Inc.. "Hologic receives FDA approval for hydroxyprogesterone caproate injection". News-Medical. https://www.news-medical.net/news/20110204/Hologic-receives-FDA-approval-for-hydroxyprogesterone-caproate-injection.aspx. (accessed February 08, 2023).

  • Harvard

    Hologic, Inc.. 2019. Hologic receives FDA approval for hydroxyprogesterone caproate injection. News-Medical, viewed 08 February 2023, https://www.news-medical.net/news/20110204/Hologic-receives-FDA-approval-for-hydroxyprogesterone-caproate-injection.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post
You might also like...
Hologic enters definitive agreement to acquire Gen-Probe